POLICYSTIC OVARIAN SYNDROME AND NITRIC OXIDE. EFFECTS OF TREATMENT WITH N-ACETYLCYSTEINE AND ARGININE
- Conditions
- TO RESTORE A PHYSIOLOGICAL MESTRUAL CICLICITY AND OVULATION INCREASING THE PRODUCTION OF NITRIC OXIDE IN SUBJECTS WITH POLICYSTIC OVARIAN SYNDROME BY MEANS OF ARGININE AND ACETYLCYSTEINE ADMINISTRATIONMedDRA version: 9.1Level: LLTClassification code 10036049Term: Polycystic ovaries
- Registration Number
- EUCTR2005-002091-15-IT
- Lead Sponsor
- AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: INDUZIONE DI UNA FISIOLOGICA CICLICITA' MESTRUALE CON RIPRISTINO DELL'OVULAZIONE <br>;Secondary Objective: RIDUZIONE DEL TASSO DI ANDROGENI CIRCOLANTI; INCREMENTO DELLA SENSIBILITA' PERIFERICA ALL'INSULINA E MIGLIORAMENTO DEL PROFILO LIPIDICO; RIDUZIONE DEI PARAMETRI OSSIDATIVI E MIGLIORAMENTO DEGLI INDICI DI FUNZIONALITA' ENDOTELIALE ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method